Literature DB >> 24420706

Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients.

Nittaya Chamadol1, Chawalit Pairojkul, Narong Khuntikeo, Vallop Laopaiboon, Watcharin Loilome, Paiboon Sithithaworn, Paungrat Yongvanit.   

Abstract

Cholangiocarcinoma (CCA) has no specific clinical signs and symptoms and non-specific bio- and tumor-markers in the early disease stage. Usually patients present to tertiary care with advanced disease stage. In order to detect early cases of CCA that may present as a mass, dilatation of intrahepatic duct or combination, ultrasonography is accepted as a powerful imaging tool. A smaller mass or bile duct segmental dilatation requires further imaging for characterization, including computerized tomography (CT) or magnetic resonance imaging (MRI). We examined whether liver echo pattern was correlated with high risk for CCA in an endemic area of Opisthorchis viverrini (Ov). Ov infestation caused chronic inflammation of the biliary tree by periductal fibrosis (PDF), which may subsequently lead to CCA development. In our study, a World Health Organization classification of pattern of increased periportal echo (IPE) for schistosomiasis was applied. Two CCA patients gave consent for operation. Histopathological diagnosis showed both had cholangiocarcinoma with periductal fibrosis of the non-tumorous area of the liver. Ultrasonography was used to compare the non-tumorous area with parenchymal echo pattern and was shown to have an early CCA detection role and a surveillance role in an endemic area of Ov by detection of PDF.
© 2014 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Cholangiocarcinoma; Increased periductal echo; Periductal fibrosis; Ultrasonography diagnosis

Mesh:

Year:  2014        PMID: 24420706     DOI: 10.1002/jhbp.64

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  21 in total

1.  Differential Protein Expression Marks the Transition From Infection With Opisthorchis viverrini to Cholangiocarcinoma.

Authors:  Jarinya Khoontawad; Chawalit Pairojkul; Rucksak Rucksaken; Porntip Pinlaor; Chaisiri Wongkham; Puangrat Yongvanit; Ake Pugkhem; Alun Jones; Jordan Plieskatt; Jeremy Potriquet; Jeffery Bethony; Somchai Pinlaor; Jason Mulvenna
Journal:  Mol Cell Proteomics       Date:  2017-02-23       Impact factor: 5.911

2.  Preliminary genetic evidence of two different populations of Opisthorchis viverrini in Lao PDR.

Authors:  Opal Pitaksakulrat; Nadda Kiatsopit; Nonglak Laoprom; Bonnie L Webster; Joanne P Webster; Poppy H L Lamberton; Thewarach Laha; Ross H Andrews; Trevor N Petney; David Blair; Elizabeth J Carlton; Robert C Spear; Paiboon Sithithaworn
Journal:  Parasitol Res       Date:  2017-02-25       Impact factor: 2.289

Review 3.  Cholangiocarcinoma.

Authors:  Paul J Brindley; Melinda Bachini; Sumera I Ilyas; Shahid A Khan; Alex Loukas; Alphonse E Sirica; Bin Tean Teh; Sopit Wongkham; Gregory J Gores
Journal:  Nat Rev Dis Primers       Date:  2021-09-09       Impact factor: 65.038

4.  Analysis of the population genetics of Opisthorchis viverrini sensu lato in the Nam Ngum River wetland, Lao PDR, by multilocus enzyme electrophoresis.

Authors:  Nadda Kiatsopit; Paiboon Sithithaworn; Weerachai Saijuntha; Opal Pitaksakulrat; Trevor N Petney; Joanne P Webster; Ross H Andrews
Journal:  Parasitol Res       Date:  2014-07-18       Impact factor: 2.289

5.  Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis.

Authors:  Chompunoot Wangboon; Puangrat Yongvanit; Watcharin Loilome; Raynoo Thanan; Chanika Worasith; Chatanun Eamudomkarn; Nittaya Chamadol; Eimorn Mairiang; Jiraporn Sithithaworn; Prasert Saichua; Banchob Sripa; Narong Khuntikeo; Jeffrey M Bethony; Paiboon Sithithaworn
Journal:  Am J Trop Med Hyg       Date:  2018-04-05       Impact factor: 2.345

6.  Teleconsultation ultrasonography: a new weapon to combat cholangiocarcinoma.

Authors:  Nittaya Chamadol; Vallop Laopaiboon; Jiraporn Srinakarin; Watcharin Loilome; Puangrat Yongvanit; Bandit Thinkhamrop; Narong Khuntikeo
Journal:  ESMO Open       Date:  2017-08-22

7.  Improving the Detection of Cholangiocarcinoma: In vitro MRI-Based Study Using Local Coils and T2 Mapping.

Authors:  Narong Khuntikeo; Attapol Titapun; Nittaya Chamadol; Wuttisak Boonphongsathien; Prakasit Sa-Ngiamwibool; Simon D Taylor-Robinson; Christopher A Wadsworth; Shuo Zhang; Evdokia M Kardoulaki; Ian R Young; Richard R A Syms
Journal:  Hepat Med       Date:  2020-03-24

8.  Levels of 8-OxodG Predict Hepatobiliary Pathology in Opisthorchis viverrini Endemic Settings in Thailand.

Authors:  Prasert Saichua; Anna Yakovleva; Christine Kamamia; Amar R Jariwala; Jiraporn Sithithaworn; Banchob Sripa; Paul J Brindley; Thewarach Laha; Eimorn Mairiang; Chawalit Pairojkul; Narong Khuntikeo; Jason Mulvenna; Paiboon Sithithaworn; Jeffrey M Bethony
Journal:  PLoS Negl Trop Dis       Date:  2015-07-31

9.  A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand.

Authors:  Narong Khuntikeo; Watcharin Loilome; Bandit Thinkhamrop; Nittaya Chamadol; Puangrat Yongvanit
Journal:  PLoS Negl Trop Dis       Date:  2016-01-21

10.  Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis.

Authors:  Wassana Jamnongkan; Malinee Thanee; Puangrat Yongvanit; Watcharin Loilome; Raynoo Thanan; Phongsaran Kimawaha; Tidarat Boonmars; Runglawan Silakit; Nisana Namwat; Anchalee Techasen
Journal:  PeerJ       Date:  2018-01-22       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.